Integrated Drug Discovery

Integrated Solutions in Drug Discovery - From Concept to Candidate

Our Integrated Drug Discovery services model offers a seamless and comprehensive pathway from target validation through to pre-clinical candidate selection. By integrating expert knowledge across various therapeutic areas, LAXAI Life Sciences offers innovative solutions that accelerate your small molecule R&D and drug discovery programs.

From concept to clinic, we pioneer the journey of drug discovery services with our state-of-the-art facilities and multidisciplinary scientific functions within a robust Contract Research, Development, and Manufacturing Organization (CRDMO) framework.

medicinal chemistry

Biology

DMPK

toxicology

A Full-Spectrum Drug Discovery Partner

Comprehensive Drug Discovery Solution

Seamlessly combines expertise from target validation through to pre-clinical candidate selection, positioning LAXAI Life Sciences as a leading drug discovery company and CRDMO services provider.

Specialized Services Under One Roof

Offers a range of specialized drug discovery services including medicinal chemistry, discovery biology, DMPK, and toxicology, ensuring integrated execution across all stages.

Innovation and Efficiency

Focuses on innovation and efficiency to deliver clinically viable solutions across multiple therapeutic areas, strengthening capabilities in pharmaceutical research and development.

State-of-the-Art Facilities

Our core strength lies in utilizing state-of-the-art facilities and multidisciplinary scientific expertise to advance integrated drug discovery and preclinical development.

Tailored Services

Dedicated to customizing CRDMO services to meet each client's unique needs, ensuring an efficient and scalable drug discovery process.

Pioneering Drug Discovery

Our expert team passionately leads the drug discovery journey from concept to clinic, reinforcing LAXAI Life Sciences as a trusted small molecule drug discovery partner.

Our multidisciplinary experts drive daily progress and regularly report to the Leadership and Steering Committee. Under the facilitation of the Project Manager (PM), cross-functional communication fosters seamless collaboration at all stages. Regular reviews and decision points strengthen our governance model, enhancing evaluation, transparency, and accountability. We prioritize continuous improvement, using insights from past projects to refine future strategies.

Our Collaborative Approach

Laxai’s integrated drug discovery (IDD) process is powered by a strategic model aimed at optimizing resources and fostering transparent decision-making. Central to this model is the Joint Steering Committee (JSC), comprising senior executives and stakeholders from various departments, guiding project direction.

Key verticals under the Joint Steering Committee

chemistry

Biology

DMPK project leads

Project Management (PM)

Supply Chain Management (SCM)

Compound Management System (CMS)

This adaptable framework promotes improved collaboration and decision-making, accelerating the development of innovative therapies at Laxai.

Our comprehensive range of drug discovery and development services will support you at every stage

Precision Target Discovery

We use advanced techniques to identify and validate biological targets essential for understanding disease mechanisms. Our strategy prioritizes targets with the highest potential impact.

Hit Identification and Refinement

Using cutting-edge techniques, we identify and refine small molecule compounds that effectively interact with target proteins. This ensures a strong starting point for drug discovery

Thorough Pre-Clinical Evaluation

Prior to clinical trials, we conduct comprehensive studies to assess pharmacokinetics, safety, and formulation. This meticulous preparation sets the stage for successful clinical development.

Expert Regulatory Guidance

Navigating the regulatory landscape is complex, but we provide expert support aevery step of the way. From IND submissions to agency interactions, we ensure compliance and efficiency.

Standout features of Integrated Drug Discovery Service

Enhance decision-making efficiency through meticulous SAR analysis.
Superior drug candidates boast enhanced efficacy and safety.
Lower project attrition rates and boost drug discovery and development success with superior candidates that offer enhanced efficacy and safety
Harness cutting-edge technologies dedicated to drug discovery.
Foster innovation through cross-disciplinary collaboration.